Loading…

Uroprotective Effect of Pentoxifylline in Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats

ABSTRACT The role of phosphodiesterase inhibitor, pentoxifylline, in the prevention of cyclophosphamide‐induced hemorrhagic cystitis was evaluated in a rat model. Hemorrhagic cystitis was induced in rats by an intraperitoneal (i.p.) injection of a single dose of cyclophosphamide (150 mg/kg). Pentoxi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biochemical and molecular toxicology 2013-07, Vol.27 (7), p.343-350
Main Author: Abo-Salem, Osama M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4244-1788be7ba476a7d5dad2dcf62c564796f2e9f55d209301d182a44ebc407b27ee3
cites cdi_FETCH-LOGICAL-c4244-1788be7ba476a7d5dad2dcf62c564796f2e9f55d209301d182a44ebc407b27ee3
container_end_page 350
container_issue 7
container_start_page 343
container_title Journal of biochemical and molecular toxicology
container_volume 27
creator Abo-Salem, Osama M.
description ABSTRACT The role of phosphodiesterase inhibitor, pentoxifylline, in the prevention of cyclophosphamide‐induced hemorrhagic cystitis was evaluated in a rat model. Hemorrhagic cystitis was induced in rats by an intraperitoneal (i.p.) injection of a single dose of cyclophosphamide (150 mg/kg). Pentoxifylline (150 mg/kg/day/ip) was administered for 10 days followed by cyclophosphamide. Hemorrhagic cystitis was well characterized macroscopically, microscopically, and biochemically. Cyclophosphamide induced bladder injury including acute severe inflammation, vascular congestion, severe edema, hemorrhage, inflammatory cell infiltration in the lamina propria, and epithelial denudation; as well as it notably elevated serum inflammatory cytokines (tumor necrosis factor‐α, interleukin‐6, and interleukin‐1β), bladder content of malondialdehyde and total nitrate, accompanied with depletion of bladder antioxidant enzymes activities (glutathione peroxidase, superoxide dismutase, glutathione‐S‐transferase, and catalase). Prior administration of pentoxifylline improved all biochemical and histologic alterations induced by the cytotoxic drug cyclophosphamide. In conclusion, pentoxifylline has proven uroprotective efficacy in the cyclophosphamide‐induced hemorrhagic cystitis model, possibly through modulating the release of inflammatory cytokines and nitric oxide and restoring the oxidant/antioxidant balance. © 2013 Wiley Periodicals, Inc. J BiochemMol Toxicol 27:343‐350, 2013; View this article online at wileyonlinelibrary.com. DOI 10.1002/jbt.21494
doi_str_mv 10.1002/jbt.21494
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1434033438</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1434033438</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4244-1788be7ba476a7d5dad2dcf62c564796f2e9f55d209301d182a44ebc407b27ee3</originalsourceid><addsrcrecordid>eNqF0U1P3DAQBmALtSoUeugfqCL10h4C_oodH9sFFhAChEAcLceedL1N4q2dFPbf17DAoVLV08zhmVcavQh9JHifYEwPls24TwlXfAvtEKxUibkgb572qhRC4m30PqUlxrhSsnqHtikTKq9yB-nbGFYxjGBH_xuKo7bNWxHa4gqGMTz4dt11foDCD8VsbbuwWoS0WpjeOyhPBzdZcMUJ9CHGhfnhbUZp9KNPjwfXZkx76G1rugQfnucuuj0-upmdlOeX89PZt_PScsp5SWRdNyAbw6Uw0lXOOOpsK6itBJdKtBRUW1WOYsUwcaSmhnNoLMeyoRKA7aIvm9z8zK8J0qh7nyx0nRkgTEkTzjhmjLP6_5QpJmtJa5zp57_oMkxxyI9kJRnlmCuR1deNsjGkFKHVq-h7E9eaYP1YkM4F6aeCsv30nDg1PbhX-dJIBgcbcO87WP87SZ99v3mJLDcXPo3w8Hph4k8tJJOVvruY64uzw-v54YzqK_YHt7yo9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1373240496</pqid></control><display><type>article</type><title>Uroprotective Effect of Pentoxifylline in Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Abo-Salem, Osama M.</creator><creatorcontrib>Abo-Salem, Osama M.</creatorcontrib><description>ABSTRACT The role of phosphodiesterase inhibitor, pentoxifylline, in the prevention of cyclophosphamide‐induced hemorrhagic cystitis was evaluated in a rat model. Hemorrhagic cystitis was induced in rats by an intraperitoneal (i.p.) injection of a single dose of cyclophosphamide (150 mg/kg). Pentoxifylline (150 mg/kg/day/ip) was administered for 10 days followed by cyclophosphamide. Hemorrhagic cystitis was well characterized macroscopically, microscopically, and biochemically. Cyclophosphamide induced bladder injury including acute severe inflammation, vascular congestion, severe edema, hemorrhage, inflammatory cell infiltration in the lamina propria, and epithelial denudation; as well as it notably elevated serum inflammatory cytokines (tumor necrosis factor‐α, interleukin‐6, and interleukin‐1β), bladder content of malondialdehyde and total nitrate, accompanied with depletion of bladder antioxidant enzymes activities (glutathione peroxidase, superoxide dismutase, glutathione‐S‐transferase, and catalase). Prior administration of pentoxifylline improved all biochemical and histologic alterations induced by the cytotoxic drug cyclophosphamide. In conclusion, pentoxifylline has proven uroprotective efficacy in the cyclophosphamide‐induced hemorrhagic cystitis model, possibly through modulating the release of inflammatory cytokines and nitric oxide and restoring the oxidant/antioxidant balance. © 2013 Wiley Periodicals, Inc. J BiochemMol Toxicol 27:343‐350, 2013; View this article online at wileyonlinelibrary.com. DOI 10.1002/jbt.21494</description><identifier>ISSN: 1095-6670</identifier><identifier>EISSN: 1099-0461</identifier><identifier>DOI: 10.1002/jbt.21494</identifier><identifier>PMID: 23695977</identifier><identifier>CODEN: JBMTFQ</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Animals ; Antineoplastic Agents, Alkylating - adverse effects ; Antineoplastic Agents, Alkylating - pharmacology ; Antioxidants - metabolism ; Cyclophosphamide ; Cyclophosphamide - adverse effects ; Cyclophosphamide - pharmacology ; Cystitis - blood ; Cystitis - chemically induced ; Cystitis - pathology ; Cystitis - prevention &amp; control ; Cytokines - blood ; Disease Models, Animal ; Free Radical Scavengers - pharmacology ; Hemorrhage - blood ; Hemorrhage - chemically induced ; Hemorrhage - pathology ; Hemorrhage - prevention &amp; control ; Hemorrhagic Cystitis ; Malondialdehyde - metabolism ; Nitric Oxide - metabolism ; Oxidoreductases - metabolism ; Pentoxifylline ; Pentoxifylline - pharmacokinetics ; Rats ; Urinary Bladder - metabolism ; Urinary Bladder - pathology ; Uroprotective</subject><ispartof>Journal of biochemical and molecular toxicology, 2013-07, Vol.27 (7), p.343-350</ispartof><rights>2013 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4244-1788be7ba476a7d5dad2dcf62c564796f2e9f55d209301d182a44ebc407b27ee3</citedby><cites>FETCH-LOGICAL-c4244-1788be7ba476a7d5dad2dcf62c564796f2e9f55d209301d182a44ebc407b27ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23695977$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abo-Salem, Osama M.</creatorcontrib><title>Uroprotective Effect of Pentoxifylline in Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats</title><title>Journal of biochemical and molecular toxicology</title><addtitle>J Biochem Mol Toxicol</addtitle><description>ABSTRACT The role of phosphodiesterase inhibitor, pentoxifylline, in the prevention of cyclophosphamide‐induced hemorrhagic cystitis was evaluated in a rat model. Hemorrhagic cystitis was induced in rats by an intraperitoneal (i.p.) injection of a single dose of cyclophosphamide (150 mg/kg). Pentoxifylline (150 mg/kg/day/ip) was administered for 10 days followed by cyclophosphamide. Hemorrhagic cystitis was well characterized macroscopically, microscopically, and biochemically. Cyclophosphamide induced bladder injury including acute severe inflammation, vascular congestion, severe edema, hemorrhage, inflammatory cell infiltration in the lamina propria, and epithelial denudation; as well as it notably elevated serum inflammatory cytokines (tumor necrosis factor‐α, interleukin‐6, and interleukin‐1β), bladder content of malondialdehyde and total nitrate, accompanied with depletion of bladder antioxidant enzymes activities (glutathione peroxidase, superoxide dismutase, glutathione‐S‐transferase, and catalase). Prior administration of pentoxifylline improved all biochemical and histologic alterations induced by the cytotoxic drug cyclophosphamide. In conclusion, pentoxifylline has proven uroprotective efficacy in the cyclophosphamide‐induced hemorrhagic cystitis model, possibly through modulating the release of inflammatory cytokines and nitric oxide and restoring the oxidant/antioxidant balance. © 2013 Wiley Periodicals, Inc. J BiochemMol Toxicol 27:343‐350, 2013; View this article online at wileyonlinelibrary.com. DOI 10.1002/jbt.21494</description><subject>Animals</subject><subject>Antineoplastic Agents, Alkylating - adverse effects</subject><subject>Antineoplastic Agents, Alkylating - pharmacology</subject><subject>Antioxidants - metabolism</subject><subject>Cyclophosphamide</subject><subject>Cyclophosphamide - adverse effects</subject><subject>Cyclophosphamide - pharmacology</subject><subject>Cystitis - blood</subject><subject>Cystitis - chemically induced</subject><subject>Cystitis - pathology</subject><subject>Cystitis - prevention &amp; control</subject><subject>Cytokines - blood</subject><subject>Disease Models, Animal</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Hemorrhage - blood</subject><subject>Hemorrhage - chemically induced</subject><subject>Hemorrhage - pathology</subject><subject>Hemorrhage - prevention &amp; control</subject><subject>Hemorrhagic Cystitis</subject><subject>Malondialdehyde - metabolism</subject><subject>Nitric Oxide - metabolism</subject><subject>Oxidoreductases - metabolism</subject><subject>Pentoxifylline</subject><subject>Pentoxifylline - pharmacokinetics</subject><subject>Rats</subject><subject>Urinary Bladder - metabolism</subject><subject>Urinary Bladder - pathology</subject><subject>Uroprotective</subject><issn>1095-6670</issn><issn>1099-0461</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqF0U1P3DAQBmALtSoUeugfqCL10h4C_oodH9sFFhAChEAcLceedL1N4q2dFPbf17DAoVLV08zhmVcavQh9JHifYEwPls24TwlXfAvtEKxUibkgb572qhRC4m30PqUlxrhSsnqHtikTKq9yB-nbGFYxjGBH_xuKo7bNWxHa4gqGMTz4dt11foDCD8VsbbuwWoS0WpjeOyhPBzdZcMUJ9CHGhfnhbUZp9KNPjwfXZkx76G1rugQfnucuuj0-upmdlOeX89PZt_PScsp5SWRdNyAbw6Uw0lXOOOpsK6itBJdKtBRUW1WOYsUwcaSmhnNoLMeyoRKA7aIvm9z8zK8J0qh7nyx0nRkgTEkTzjhmjLP6_5QpJmtJa5zp57_oMkxxyI9kJRnlmCuR1deNsjGkFKHVq-h7E9eaYP1YkM4F6aeCsv30nDg1PbhX-dJIBgcbcO87WP87SZ99v3mJLDcXPo3w8Hph4k8tJJOVvruY64uzw-v54YzqK_YHt7yo9A</recordid><startdate>201307</startdate><enddate>201307</enddate><creator>Abo-Salem, Osama M.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201307</creationdate><title>Uroprotective Effect of Pentoxifylline in Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats</title><author>Abo-Salem, Osama M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4244-1788be7ba476a7d5dad2dcf62c564796f2e9f55d209301d182a44ebc407b27ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Antineoplastic Agents, Alkylating - adverse effects</topic><topic>Antineoplastic Agents, Alkylating - pharmacology</topic><topic>Antioxidants - metabolism</topic><topic>Cyclophosphamide</topic><topic>Cyclophosphamide - adverse effects</topic><topic>Cyclophosphamide - pharmacology</topic><topic>Cystitis - blood</topic><topic>Cystitis - chemically induced</topic><topic>Cystitis - pathology</topic><topic>Cystitis - prevention &amp; control</topic><topic>Cytokines - blood</topic><topic>Disease Models, Animal</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Hemorrhage - blood</topic><topic>Hemorrhage - chemically induced</topic><topic>Hemorrhage - pathology</topic><topic>Hemorrhage - prevention &amp; control</topic><topic>Hemorrhagic Cystitis</topic><topic>Malondialdehyde - metabolism</topic><topic>Nitric Oxide - metabolism</topic><topic>Oxidoreductases - metabolism</topic><topic>Pentoxifylline</topic><topic>Pentoxifylline - pharmacokinetics</topic><topic>Rats</topic><topic>Urinary Bladder - metabolism</topic><topic>Urinary Bladder - pathology</topic><topic>Uroprotective</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abo-Salem, Osama M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of biochemical and molecular toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abo-Salem, Osama M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uroprotective Effect of Pentoxifylline in Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats</atitle><jtitle>Journal of biochemical and molecular toxicology</jtitle><addtitle>J Biochem Mol Toxicol</addtitle><date>2013-07</date><risdate>2013</risdate><volume>27</volume><issue>7</issue><spage>343</spage><epage>350</epage><pages>343-350</pages><issn>1095-6670</issn><eissn>1099-0461</eissn><coden>JBMTFQ</coden><abstract>ABSTRACT The role of phosphodiesterase inhibitor, pentoxifylline, in the prevention of cyclophosphamide‐induced hemorrhagic cystitis was evaluated in a rat model. Hemorrhagic cystitis was induced in rats by an intraperitoneal (i.p.) injection of a single dose of cyclophosphamide (150 mg/kg). Pentoxifylline (150 mg/kg/day/ip) was administered for 10 days followed by cyclophosphamide. Hemorrhagic cystitis was well characterized macroscopically, microscopically, and biochemically. Cyclophosphamide induced bladder injury including acute severe inflammation, vascular congestion, severe edema, hemorrhage, inflammatory cell infiltration in the lamina propria, and epithelial denudation; as well as it notably elevated serum inflammatory cytokines (tumor necrosis factor‐α, interleukin‐6, and interleukin‐1β), bladder content of malondialdehyde and total nitrate, accompanied with depletion of bladder antioxidant enzymes activities (glutathione peroxidase, superoxide dismutase, glutathione‐S‐transferase, and catalase). Prior administration of pentoxifylline improved all biochemical and histologic alterations induced by the cytotoxic drug cyclophosphamide. In conclusion, pentoxifylline has proven uroprotective efficacy in the cyclophosphamide‐induced hemorrhagic cystitis model, possibly through modulating the release of inflammatory cytokines and nitric oxide and restoring the oxidant/antioxidant balance. © 2013 Wiley Periodicals, Inc. J BiochemMol Toxicol 27:343‐350, 2013; View this article online at wileyonlinelibrary.com. DOI 10.1002/jbt.21494</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>23695977</pmid><doi>10.1002/jbt.21494</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1095-6670
ispartof Journal of biochemical and molecular toxicology, 2013-07, Vol.27 (7), p.343-350
issn 1095-6670
1099-0461
language eng
recordid cdi_proquest_miscellaneous_1434033438
source Wiley-Blackwell Read & Publish Collection
subjects Animals
Antineoplastic Agents, Alkylating - adverse effects
Antineoplastic Agents, Alkylating - pharmacology
Antioxidants - metabolism
Cyclophosphamide
Cyclophosphamide - adverse effects
Cyclophosphamide - pharmacology
Cystitis - blood
Cystitis - chemically induced
Cystitis - pathology
Cystitis - prevention & control
Cytokines - blood
Disease Models, Animal
Free Radical Scavengers - pharmacology
Hemorrhage - blood
Hemorrhage - chemically induced
Hemorrhage - pathology
Hemorrhage - prevention & control
Hemorrhagic Cystitis
Malondialdehyde - metabolism
Nitric Oxide - metabolism
Oxidoreductases - metabolism
Pentoxifylline
Pentoxifylline - pharmacokinetics
Rats
Urinary Bladder - metabolism
Urinary Bladder - pathology
Uroprotective
title Uroprotective Effect of Pentoxifylline in Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A08%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uroprotective%20Effect%20of%20Pentoxifylline%20in%20Cyclophosphamide-Induced%20Hemorrhagic%20Cystitis%20in%20Rats&rft.jtitle=Journal%20of%20biochemical%20and%20molecular%20toxicology&rft.au=Abo-Salem,%20Osama%20M.&rft.date=2013-07&rft.volume=27&rft.issue=7&rft.spage=343&rft.epage=350&rft.pages=343-350&rft.issn=1095-6670&rft.eissn=1099-0461&rft.coden=JBMTFQ&rft_id=info:doi/10.1002/jbt.21494&rft_dat=%3Cproquest_cross%3E1434033438%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4244-1788be7ba476a7d5dad2dcf62c564796f2e9f55d209301d182a44ebc407b27ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1373240496&rft_id=info:pmid/23695977&rfr_iscdi=true